UChicago Medicine Comprehensive Cancer Center
Multigenerational Asian women, stock photo

Women who inherit a mutation in BRCA1 or BRCA2 have an increased risk of getting breast or ovarian cancer at an early age, developing breast cancer in both breasts and/or developing more than one type of cancer during their lifetime. Men who inherit these mutations have a higher risk for developing male breast cancer, prostate cancer and other cancers.

The Society of Gynecologic Oncology recommends that all women who have a diagnosis of ovarian/fallopian tube cancer undergo genetic counseling and testing. The goal of risk assessment is to prevent cancer either through a surgical procedure or chemoprevention medications, or to detect it at an early stage.

Our Hereditary Breast and Ovarian Cancer Risk and Prevention Clinic offers personalized risk assessment and prevention recommendations for patients and families who may be at increased risk for developing breast and/or ovarian cancer due to genetic factors. Our services include:

  • Breast and ovarian cancer risk assessment and genetic testing
  • Cancer prevention counseling and strategies
  • High-risk breast cancer screening and surveillance, including breast MRI
  • Ovarian cancer screening and prevention
  • Coordinated care for individuals with an inherited mutation that increases the risk of breast, ovarian and/or other cancers

Assessing Risk 

Evaluation and risk assessment are offered for individuals or families who have the following in their medical history:

A personal history of:

  • Early onset breast cancer (before the age of 50; or, if type of breast cancer is triple negative, then before the age of 60)
  • Bilateral breast cancer
  • Breast, ovarian, thyroid or endometrial cancer
  • Male breast cancer
  • Ovarian or fallopian tube cancer
  • Breast and/or ovarian cancer and ethnic background with an increased risk of inherited forms of breast cancer (for example, Ashkenazi Jewish ancestry)

A family history of:

Appointments

Call 1-855-702-8222 or complete the form below to request an appointment for hereditary breast and ovarian cancer risk assessment.

 

After Breast Cancer, Bronzeville Woman Triumphs as a Bodybuilder

Breast cancer with a genetic mutation derailed Erica Langley's plans to become a bodybuilder. But after an aggressive, personalized treatment plan, she conquered both cancer and her bodybuilding competition.
breast cancer survivor and bodybuilding champion Erica Langley

Breast & Ovarian Cancer Risk & Prevention Physician Team

Request an Appointment

We are currently experiencing a high volume of inquiries, leading to delayed response times. For faster assistance, please call 1-855-702-8222 to schedule your appointment.

If you have symptoms of an urgent nature, please call your doctor or go to the emergency room immediately.

For Referring Physicians

To refer a patient, please call UCM Physician Connect at 1-800-824-2282.

By submitting this form you acknowledge the risk of sending this information by email and agree not to hold the University of Chicago or University of Chicago Medical Center liable for any damages you may incur as a result of the transfer or use of this information. The use or transmittal of this form does not create a physician-contact relationship. More information regarding the confidentiality of this request can be found in our Privacy Policy.

* Indicates required field

By submitting this form you acknowledge the risk of sending this information by email and agree not to hold the University of Chicago or University of Chicago Medical Center liable for any damages you may incur as a result of the transfer or use of this information. The use or transmittal of this form does not create a physician-contact relationship. More information regarding the confidentiality of this request can be found in our Privacy Policy.
medical oncologist Olwen Hahn, MD

Cancer Care Second Opinions

Request a second opinion from UChicago Medicine cancer care experts.

researcher in cancer lab

Clinical Trials for Breast Cancer

We're actively conducting phase I, II and III clinical trials for breast cancer.

Stacy Lindau, MD, talking with a patient

Program in Integrative Sexual Medicine (PRISM) for Women & Girls with Cancer

PRISM is a program designed to identify, prevent and treat sexual health problems in female cancer patients and survivors.

WISDOM Study and Breast Cancer Prevention: Q & A

Video placeholder

WISDOM Study and Breast Cancer Prevention: Q & A

The WISDOM study is a national research effort to determine if breast cancer screening can be made better by personalizing each woman's mammogram schedule. Learn about the study and important facts about breast cancer risk and prevention.
Watch Video With Transcript